← Leaderboards
Kevin Max Levine
University Of Pittsburgh At Pittsburgh
$170,265
Attributed
$170,265
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50K · FY2017–20$100K$75K$50K$25K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$170,265 · 1
By mechanism
F30$170,265 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Jun Chen$22,616,112
- David A Lewis$38,866,023
- Kenneth Alan Perkins$15,843,214
- David E Kelley$11,733,618
- Gerard L Apodaca$21,037,813
Others in their field
Other Emerging Leaders on “Bioinformatics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$190,146,572
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedmand · Leidos Biomedical Research, Inc.$50,302,300
- Lynn Briscoe · Leidos Biomedical Research, Inc.$50,165,970
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$16,767,001
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
BioinformaticsGene Expression ProfilingCell LineBiological MarkersCellsFibroblast Growth Factor ReceptorsClinical DevelopmentClinical TrialsComplementCell ModelCultured CellsDatabasesCell SurvivalCell GrowthDeprivationDifferential ExpressionEducational Process Of InstructingEfficacy TestingEndocrineEstrogen Receptor AlphaEstrogensFgfr4 GeneFibroblast Growth FactorGenes
Grant awards (4)
Combination FGFR4 and ER-Targeted Therapy for Invasive Lobular Carcinoma$45,273
F30 · FY2020 · CA · contact PI
Combination FGFR4 and ER-Targeted Therapy for Invasive Lobular Carcinoma$50,016
F30 · FY2019 · CA · contact PI
Combination FGFR4 and ER-Targeted Therapy for Invasive Lobular Carcinoma$45,339
F30 · FY2018 · CA · contact PI
Combination FGFR4 and ER-Targeted Therapy for Invasive Lobular Carcinoma$29,637
F30 · FY2017 · CA · contact PI